With their capability to inhibit the formation of amyloid-β peptide (Aβ) fibril, norepinephrine (NE), and other catechol derivatives have been considered for the potential treatment of Alzheimer's disease (AD). Such treatment, however, remains debatable because of the diverse functions of Aβ and NE in AD pathology. Moreover, the complicated oxidation accompanying NE has caused the majority of the previous research to focus on the binding of NE oxides onto Aβ. The molecular mechanism by which Aβ interacts with the reduction state of NE, which is correlated with the brain function, should be urgently explored. In this work, by controlling rigorous anaerobic experimental conditions, the molecular mechanism of the Aβ/NE interaction was investigated, and two binding sites were revealed. , and Aβ induced lower cell viability than free Cu 2+ , indicating the significant negative effect of excessive NE on AD progression. These data revealed the possible pathway of NE-induced damage in AD brain, which is significant for understanding the function of NE in Aβ-involved AD neuropathology and for designing an NE-related therapeutic strategy for AD.
Introduction
Despite the continuous debates on their function in Alzheimer's disease (AD) [1] , amyloid-β peptide (Aβ, Fig. 1A ) aggregates identified in the plaques of the hippocampus and neocortical regions of the human brain are considered the neuropathology hallmarks of neurodegenerative AD [2, 3] . The amphipathic nature of Aβ aggregates facilitates their own interaction with anionic and hydrophobic components of the cell membranes [4, 5] and induces cytotoxicity [6] . Meanwhile, hydrophilic Aβ segment can bind with Cu 2+ , thereby reducing the amount of free Cu 2+ and protecting the neurons from Cu 2+ -induced reactive oxygen species (ROS) damage [7, 8] . Given that the oligomer intermediates are toxic to neuronal cells [9] [10] [11] , researchers focused on discovering complexes that can inhibit Aβ aggregation (oligomers or fibrils). Several studies have reported that norepinephrine (NE) can disaggregate the Aβ fibril and delay Aβ fibril formation in vitro [12, 13] . Based on these observations, NE and other catechol derivatives have been shown to be potential inhibitors of Aβ aggregation and can serve as effective treatment of AD [13] [14] [15] [16] . However, due to insufficient findings on the effects of NE on Aβ/Cu 2+ interaction and subsequent oxidation stress, the strategy for AD therapy is still debatable. In this event, the molecular mechanism of the Aβ/NE interaction and the effect of NE on Aβ/Cu 2+ interaction should be urgently revealed. Unlike exogenous anti-aggregation agents, NE is a neurotransmitter. NE plays an important role in regulating cognitive and behavioral functions [17] , and influences some symptoms which accompany dementia, such as depression, aggression, agitation, and psychosis [18] . Considerable evidence suggests that the dysfunction of NE in specific brain regions is important in AD. NE at high concentrations increases Aβ neurotoxicity (oxidative stress and mitochondrial dysfunction) and induces neuronal cell death [19] . Moreover, in vitro and in vivo studies have shown that NE influences several features of AD disease including inflammation, neurodegeneration, and cognitive function [20] . In addition, the protective effect of NE against amyloid toxicity via TrkB was reported [21] . NE was also reported to inhibit iron/ascorbate-stimulated lipid peroxidation due to its ability to chelate iron or scavenge free radicals [22, 23] . Given the controversial physiological functions of NE, an overall evaluation in vitro, at both the molecular and cellular levels, should be performed prior to applying NE as a means of treating AD.
Thus far, only a few studies have explored the mechanism of Aβ/NE interactions. Lysine side chain [12] and aromatic group amino acids [24] were suggested as the binding site candidates on Aβ. However, due to the susceptibility of NE to oxygen, all previous research focused on the binding of Aβ with NEoxide (NEquinone). In brain, NE is tightly controlled in its reduction state (Fig. 1B) , whether it is stored in NE vesicles or released upon exocytosis [25] . Based on the above conditions, exploring the molecular mechanism by which Aβ interacts with NE, not with its oxidation forms, is remarkably important.
In this study, the interaction of NE with Aβ in vitro, at both molecular and cellular levels, was comprehensively evaluated by controlling rigorous anaerobic experimental conditions. In particular, the molecular mechanism of the interaction, including the binding sites and dissociation constant, was explored. Moreover, the physiological significance of NE in Aβ aggregation and Aβ/Cu 2+ -induced redox stress was elucidated. The cytotoxicity of the NE/Aβ/Cu 2+ complex was also evaluated. Our results revealed a relatively different outline on NE in Aβ-related AD neuropathology that is deemed significant for the NE-related AD therapeutic strategy. ) . The mixture of penicillin and streptomycin for cell culture and cytotoxicity study was purchased from Millipore (Billerica, USA). Other regents were all of analytical grade and were used as received. All stock solutions were prepared daily with deionized water treated with a water purification system (Simplicity 185; Millipore).
Materials and Methods

Materials
Solution preparation
The samples of Aβ were diluted with phosphate-buffered saline (PBS). The Aβ stock solutions (0.5 mM) were prepared daily according to our previous procedures [8] . Briefly, lyophilized Aβ samples were dissolved in 10 mM NaOH solution, in which the aggregation of Aβ is considered effectively inhibited. Upon sonication for 1 min, the solution was centrifuged at 9500 g for 30 min to remove any insoluble particles, and the supernatants were pipetted out and were diluted with 10 mM PBS buffer (pH 7.4, 0. 
Surface plasmon resonance measurements
The measurements for flow-injection surface plasmon resonance (FI-SPR) were conducted with a BI-SPR 3000 system (Biosensing Instrument, Inc., Tempe, USA). PBS buffer (pH 7.4, 0.1 M Na 2 SO 4 ) was degassed via vacuum pumping for 30 min and was used as the carrier solution. The samples were preloaded into a 200 μl sample loop on a six-port valve and were then delivered to the flow cell with an internal volume of ca. 1.0 μl with a syringe pump (Model KDS260; KD Scientific, Holliston, USA). The instrument can cut off the dispersed front and tail ends of injected sample plugs prior to introducing the samples into the SPR sensing areas [26] . The Au films coated onto BK7 glass slides were purchased from Biosensing Instrument, Inc. and were annealed in a hydrogen flame to eliminate surface contaminants. The MUA-covered SPR chip was formed by immersing the cleaned substrate in a 4.0 mM MUA ethanol solution for 18 h [8, 27] . Upon the formation of the MUA selfassembled monolayers (SAMs), the chips were removed from the solution, rinsed with absolute ethanol and deionized water, and were then dried with nitrogen. For on-line NE immobilization, the MUA chip was mounted onto the SPR instrument. After a stable baseline was obtained, 200 μl aliquots of the EDC/NHS mixture were injected into the fluidic channel. EDC/NHS solution was prepared by mixing 0.4 M EDC and 0.1 M NHS in water right before the MUA film was activated. Subsequently, 200 μl aliquots of the NE solution were injected into the fluidic channel. The activated chips were then washed with carrier solution for 10 min. The immobilization of NE was performed by cross-linking NE molecules onto a MUA SAM via the standard amine coupling reaction [28] . This procedure was followed by injecting 1.0 M ethanolamine onto the chips to block the unreacted sites.
In all SPR experiments, the carrier solution was 10 mM PBS buffer (pH 7.4, 0.1 M Na 2 SO 4 ), and the flow rate was 30 μl/min. The kinetics analysis of the SPR data was performed as reported in our previous paper [8] . After each measurement, the surface was regenerated via one or more injections of 10 mM NaOH. The oxidation of NE was eliminated by applying nitrogen-saturated solutions in the experiments.
Electrochemical measurements
Differential pulse voltammetry (DPV) measurements were performed to detect the contents of free Cu 2+ using a Gamry Reference 600 electrochemical workstation (Gamry Instruments Co., Ltd, Warminster, PA, USA). A glassy carbon disk electrode and a platinum wire were used as the working and counter electrodes, respectively. An Ag/AgCl was used as reference electrode. The -containing solution was incubated for 10 min and filtered three times using a 2-kDa cutoff Millipore (YM-2) membrane (Millipore) to completely remove the Aβ-containing complexes. All solutions in the experiments were nitrogen-saturated.
Fluorescence measurements
Thioflavin T (THT) assays were performed in a Mikrouna Ipure glove box (Mikrouna Co., Ltd) with attainable O 2 concentration below 1 ppm. NE was added at the beginning of incubation time. All the solutions were incubated at 37°C. The THT fluorescence was measured immediately after addition of an aliquot of the incubated sample to the dye. An excitation wavelength of 415 nm, an emission at 488 nm, and an exit slit width of 10 nm were employed. THT fluorescence data were fit to a two-step autocatalytic growth model [29] to obtain the nucleation and elongation rates for Aβ aggregation. Here any monomer is irreversibly converted to fibrillar form and the fibril can then react with another monomer. The concentration of formed fibrils at time t, F t , is mathematically described by
where [M] 0 , k 1 , and k 2 are the initial monomer concentration, the nucleation rate, and the rate of fibril or aggregate growth, respectively. The production of ·OH was monitored by coumarin-3-carboxylic acid (3-CCA) fluorescence assay, as reported in our previous paper [8] . Steady-state 7-OHCCA (the production of 3-CCA interacting with ·OH) fluorescence was measured using a Hitachi F-4600 fluorescence spectrophotometer (Hitachi Co. Ltd, Japan) at room temperature. And 10 mM PBS (pH 7.4, 0.1 M Na 2 SO 4 ) was used as the buffer. An excitation wavelength of 388 nm, an emission at 450 nm, and an exit slit width of 10 nm were used. At least three replications were performed for each sample.
Cell culture and cytotoxicity SH-SY5Y cells were cultured in a medium of DMEM containing 4 mM L-glutamine/Ham's F12/FBS/mixture of penicillin and streptomycin (v/v/v/v = 44.5/44.5/10/1). For toxicity assay, cells collected at 45% confluence and resuspended in the same DMEM/F12 medium with a smaller FBS content (5%) were added into a 96-well plate, which was then placed in a humidified incubator at 37°C and under 5% CO 2 . SH-SY5Y cells were treated with Aβ-containing solutions (vide infra) for 24 h. The viability of the cells exposed to each solution was determined using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (EMD, Inc., Gibbstown, USA). Briefly, MTT was first dissolved in 10 mM PBS (pH 7.4, containing 100 mM NaCl) to 5 mg/ml. The medium was replaced by the mixture of 10% MTT (5 mg/ml) in media (v/v), and subsequently incubated for 4 h. After removal of the MTTcomprising medium, 100 μl of dimethyl sulfoxide was added into each well to dissolve the formazan precipitate. The UV-vis absorption at 490 nm in each well was recorded with a Bio-TekEL×800 plate reader (BioTek Instruments, Inc., Winooski, USA). For each type of solution, MTT assays were conducted in five separate wells, and the final viability obtained was the average from the MTT assays conducted on three different days.
Results
Monitoring of Aβ 1-42 binding to NE
Here, SPR technique was used to check the interaction between Aβ 1-42 and NE. Figure 2 shows a typical scheme of SPR responses, which corresponds to the immobilization of NE and subsequent Aβ 1-42 binding. In brief, the immobilization of NE was achieved via the EDC/NHS cross-linking reaction, which mainly connected the amino group of the NE molecule to the carboxyl end group of the MUA SAMs. Due to small molecular weight, the immobilization of NE exhibited a slight SPR angle shift [6.76 millidegrees (mdeg)]. After the unreacted MUA sites were blocked with AE, Aβ 1-42 was introduced to the immobilized NE molecules. Given that the binding of Aβ 1-42 onto AE-blocked surface induces no detectable response (Fig. 2B) , this significant SPR angle shift (32.1 mdeg) can be attributed to the binding of Aβ 1-42 onto NE. Surface regeneration was then achieved via the injection of 10 mM NaOH (completely desorbing Aβ 1-42 ), and reproducible signals were obtained via injection to regenerate the surface. After five regenerations, the binding signal was decreased by <10%. Therefore, a single chip could be repeatedly used for multiple measurements, ensuring the accuracy and reproducibility of the binding sites and kinetics research of NE interacting with Aβ.
Binding sites of Aβ 1-42 interacting with NE
The binding chemistry of Aβ interacting with NE should be thoroughly explored to reveal the effect of NE on the Aβ-related neurotoxicity. However, the mechanisms of interactions between NE and Aβ are controversial. NE easily converts to its quinone-form [30] ; hence, the majority of the previous research analyzed the quinone-form of NE and suggested the formation of the o-quinone-Aβ adduct by nucleophilic attack of a lysine side chain. Meanwhile, computational studies indicated the preferential interactions of NE with aromatic group amino acids via hydrophobic interactions. Based on these findings, NE is anticipated to interact with Aβ at more than one site, and the predominant binding mode and binding site should be confirmed.
In this study, two typical truncated forms of Aβ, hydrophilic Aβ 1-16 and hydrophobic Aβ 12-28, which are respectively related to the peptide's properties of metal coordination and peptide aggregation, were used to judge the interaction region of Aβ with NE. Figure 3A showed that the independent injections of 10 μM Aβ 1-42 , Aβ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] , and Aβ 12-28 onto the NE-modified surface induced the SPR angle shifts of 73.0, 28.8, and 3.5 mdeg, respectively. Non-specific adsorption was not evidently observed between Aβ and MUA SAM; thus, all these SPR responses can be attributed to the interaction between NE and the corresponding Aβ forms. In this event, NE can interact with both the hydrophilic and hydrophobic domains of Aβ.
The aromatic group amino acids have been indicated as the possible binding site on the NE/Aβ and NE/α-syn interactions [13] . . Figure 3B revealed that the injection of 10 μM Aβ [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] 16 is not involved in the interaction.
In Fig. 3C , the injection of 10 μM Aβ 12-25 onto the NE-modified surface produced no detectable SPR angle shift. This finding is relatively different from the results with the injection of 10 μM Aβ 12-28 , which incurred an angle shift of 3.5 mdeg. This result implied that the SNK(26-28) segment may play an important role in the interaction of hydrophobic Aβ 12-28 with NE. The interactions of NE with the individual Δ26, Δ27, and Δ28 mutants of hydrophobic Aβ 12-28 were also studied. Accordingly, all the corresponding SPR responses were no more than 2.5 mdeg, significantly smaller than those from 10 μM Aβ [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] 
Dissociation constant of Aβ interacting with NE
Dissociation constant is a basic physical parameter to evaluate the affinity between two complexes. Here, the dissociation constant of Aβ 1-42 binding to NE was determined by simulating a series of binding curves obtained at different Aβ 1-42 concentrations (Fig. 4) . The kinetics analysis of the SPR data was performed as reported in our previous paper [8] . Analyzing both the association and dissociation processes yields an estimation of the association (k a ) and dissociation (k d ) rate constants. The dissociation constant, K d , defined as k d /k a [32, 33] was listed in Table 1 .
After fitting these curves with the Scrubber program, the dissociation constant K d of 0.25 μM was obtained for the Aβ 1-42 /NE interaction. The K d of NE interacting with two truncated Aβ forms (hydrophilic Aβ 1-16 and hydrophobic Aβ 12-28 ) was also determined by simulating a series of binding curves obtained at different Aβ concentrations. The K d value of Aβ 1-16 /NE (0.59 μM) was close to that of Aβ 1-42 /NE, whereas the K d value of Aβ 12-28 /NE (4.13 μM) was larger than that of Aβ 1-42 /NE. These findings not only confirm that NE can interact with both the hydrophilic and hydrophobic domains of Aβ, but also reveal that Aβ/NE affinity is stronger at the hydrophilic domain of Aβ.
NE inhibits Aβ fibril formation
The inhibition of Aβ fibril formation has been considered as a promising strategy for treating AD. In this study, THT fluorescence intensity was measured during fibril formation to investigate the effects of NE on the formation of Aβ fibril (Fig. 5) . The control experiment was performed by incubating 20 μM Aβ monomers without NE. The time-course of THT fluorescence intensity showed a characteristic sigmoidal curve, which is composed of nucleation and elongation processes [13, 34] . In the nucleation process, oligomer formation or nucleation occurred, whereas fluorescence variation was not detected. Meanwhile, in the elongation process, the fibrils grew because the monomers attached to the ends of the former. In this case, THT fluorescence intensity increased. When a 20-μM Aβ monomer solution was incubated in the presence of 20 μM NE, the final equilibrium level of THT was slightly lower than that in the control experiment. Contrarily, the lag and elongation times were similar to those of the control experiment. However, in the case of 200 μM NE, the fluorescence intensity was dramatically decreased and the lag time was delayed by more than 2 h. In order to evaluate the effect of NE on Aβ aggregation process, all the THT fluorescence data were fit to a two-step autocatalytical growth model [29] . The obtained nucleation and elongation rates were listed in Table 2 . Obviously, NE significantly decreased both nucleation and elongation rate of Aβ with increased NE concentration. NE displayed the concentration-dependent inhibitory effects on the spontaneous Aβ fibril formation, which was consistent with its weak binding with hydrophobic Aβ segment. When NE was mixed with Aβ at equal molar ratio, due to the strong affinity of NE/Tyr 10 , the NE preferentially attached onto the hydrophilic segment, slightly affecting the Aβ aggregation process. Consequently, fluorescence intensity was moderately decreased. With the increase of NE concentration, NE 
NE inhibits the neuronal protection effect of Aβ
The preferential interaction of Aβ with NE occurs in the hydrophilic segments, which are also the donation segment for the interaction of Aβ with Cu 2+ [35, 36] . Due to the close K d values of Aβ/NE (0.25 μM) and Aβ/Cu 2+ (0.04 μM) at physiological pH, the competition binding between NE and Cu 2+ onto Aβ can be anticipated.
Here, the complex of Aβ with mixed Cu 2+ and NE can be described using chemical equilibrium equations, as shown in Fig. 6 . The complex of Aβ with Cu 2+ to Aβ-Cu 2+ is the main reaction. The presence of NE affects the form of Aβ, and then changes the apparent dissociation constant of the main reaction. The relationship of the apparent dissociation constant (K Aβ-Cu 2+ app ) and the dissociation constant (K Aβ-Cu 2+) can be expressed as follows:
which displays the near linear dependence of K Aβ-Cu 2+ app values on the NE concentration (c NE ). Therefore, with the increase of the NE concentration, the release of Cu 2+ from Aβ-Cu 2+ is anticipated.
To verify the release of Cu 2+ from Aβ-Cu
2+
, DPV was performed to detect the free Cu 2+ in two different Cu , after incubating for 10 min, all solutions were filtered with 2-kDa cutoff Millipore membrane to remove any Aβ-containing complexes. As shown in The insert in Fig. 7 , and NE with the 7-OHCCA fluorescence (Fig. 8 ) [38] . In all measurements, the excessive ascorbate acid (AA) was added as cellular reductant for the following reasons: (i) to initiate the redox cycles of both the complexed and free Cu 2+ by reducing them to Cu + [37] ; (ii) to provide as-needed hydrogen peroxide with the reduction of oxygen and to protect NE from oxidation [8, 39] . These concentration conditions were chosen because the brain is well supplied with oxygen, and ascorbate is available at high concentrations in brain cells (neuron: 10 mM, glia: 1 mM). Moreover, studies have shown that extracellular ascorbate is relatively abundant, with concentrations of 500 μM in cerebrospinal fluid and 200-400 mM in extracellular fluid [40] . Figure 8 illustrates that the free Cu 2+ generated the highest amount of ·OH, and the addition of Aβ significantly inhibited the generation of ·OH because of the coordination of Aβ/Cu
. When NE was added into the Aβ/Cu 2+ mixture solution, the ·OH -induced oxidation stress.
Viability of the neuroblastoma SH-SY5Y cells
AD was manifested by the aggregation of Aβ; yet, oxidative stress was also implicated in the pathogenesis of AD. The data presented in Figs. 5 and 8 clearly indicate the diverse effects of NE on AD pathology. In evaluating the availability of NE for treating AD, the effect of NE/Aβ interaction on incurring neuronal cell death should be investigated. To this end, the cytotoxicity of NE under various experimental conditions was assayed by evaluating the viability of the SH-SY5Y cells. Figure 9 reveals that NE displays an apparent toxicity toward the SH-SY5Y cells because of its neurotoxic oxidation intermediates. In the presence of high concentrations of AA, the oxidation of NE was inhibited, which significantly improved the cell viability (recovered back to~88%). Meanwhile, the free Cu 2+ displayed relatively high toxicity, but its toxic effect was decreased in the presence of Aβ Our results also demonstrated that the enhanced ROS improved the oxidation of excessive NE to its toxic intermediates and aggravated the neuronal cell death. In this case, the coexistence of NE, Cu 2+ , and Aβ induced the highest cytotoxicity. Given that the AD brain has high concentrations of Cu 2+ and Aβ, the significant negative effect of excessive NE in AD progression is anticipated.
Discussion
With their ability to inhibit the formation of Aβ fibril, NE and other catechol derivatives have potential use in the treatment of AD. Meanwhile, the oxidation of a catechol structure to the o-quinone, followed by the formation of the o-quinone-Aβ adduct targeting Lys 16 and Lys 28 of Aβ (both are involved in the intermolecular β-sheet region) [43] , is believed to be responsible for its antiaggregation activity. However, in brain, NE is tightly controlled in its reduction state whether it is stored in NE vesicles or released upon exocytosis. Therefore, understanding the molecular mechanism by which Aβ interacts with NE, but not its oxides, is significantly important. In this research, by controlling rigorous anaerobic experimental conditions, the molecular mechanism of the Aβ/NE interaction was explored, and two binding sites were revealed. For the binding of NE, Tyr 10 was identified as the strong binding site (K d : 0.59 μM), whereas SNK(26-28) segment as the weak binding segment (K d : 4.13 μM). Due to the dual interactions of Aβ/NE, NE plays a more complicated role than its oxide in Aβ-related neurotoxicity.
Generally, NE could affect Aβ-related neurotoxicity through three pathways. In the first pathway, NE is capable of inhibiting the aggregation of Aβ by decreasing the nucleation rate. The observed THT fluorenscence and obtained kinetic data confirmed that the significant anti-aggregation activity against Aβ was only observed at high NE concentrations, which could be attributed to the weak binding of NE with SNK(26-28) segment of Aβ. This result is relatively different from that of NE quinone, which has high affinity to Lys 16 and Lys 28 of Aβ and shows significant anti-aggregation effect The error bars represent the standard deviations.
